Internal Medicine, Endocrinology, Diabetes, & Metabolism · Stoneham, MA
NPI
1366476731
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
92montvale Ave, Suite 3675
Stoneham, MA, 02180
Phone (781) 438-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$167K
7,438 services
Medicare patients, 2024
1,034
Average age 74
Drug cost, 2024
$3.2M
7,637 prescriptions
Company payments, 2025
$900
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shant A Parseghian was code 99214 (office e&m - established), 1,292 times for 851 patients. In total Shant A Parseghian billed 7,438 services in 14 codes, and Medicare paid $167K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,292 | 851 | $96.77 | $125K |
| 83036 Blood Count | Office | 610 | 371 | $9.52 | $5,807 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 337 | 287 | $13.54 | $4,563 |
| 99204 Office E&M - New | Office | 141 | 141 | $125.07 | $18K |
| 95251 Test - Miscellaneous | Office | 108 | 66 | $27.44 | $2,964 |
| 99213 Office E&M - Established | Office | 79 | 76 | $67.09 | $5,300 |
By year: 2022 $239K for 3,841 services; 2023 $243K for 4,021 services; 2024 $167K for 7,438 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 610 | 371 | $9.52 | $5,807 |
Medicare prescription drug claims, 2024
In 2024, the drug Shant A Parseghian prescribed most often to Medicare patients was Levothyroxine Sodium, with 799 prescriptions and refills. In total Shant A Parseghian wrote 7,637 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 799 | 2,196 | 243 | $9,488 |
| Ozempic Semaglutide | 616 | 799 | 129 | $759K |
| Metformin Hcl Generic | 503 | 1,377 | 169 | $4,593 |
| Glipizide Er Glipizide | 423 | 1,163 | 131 | $9,369 |
| Mounjaro Tirzepatide | 325 | 366 | 62 | $377K |
| Metformin Hcl Er Metformin Hcl | 301 | 844 | 108 | $5,021 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 297 | 708 | 106 | $54K |
| Trulicity Dulaglutide | 293 | 465 | 89 | $438K |
| Jardiance Empagliflozin | 277 | 562 | 67 | $321K |
| Farxiga Dapagliflozin Propanediol | 268 | 465 | 69 | $258K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 265 | 687 | 99 | $25K |
| Pioglitazone Hcl Generic | 227 | 603 | 73 | $4,492 |
| Alendronate Sodium Generic | 190 | 531 | 61 | $1,793 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 166 | 401 | 64 | $135K |
| Glipizide Generic | 161 | 433 | 52 | $1,864 |
Brand drugs: 3,431 claims; generic drugs: 3,711 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shant A Parseghian $900 ($900 in general payments such as food, travel and fees) from 8 companies. The largest payer was Insulet Corporation with $565.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.